August 2, 2021
PeptiDream and Alnylam Pharmaceuticals said on July 29 that they have entered into a collaboration agreement to discover and develop peptide-siRNA conjugates to deliver RNAi therapeutics to tissues outside the liver. This alliance is expected to yield new treatment opportunities...read more